- Home
- CBUS vs ZYXI Comparison
CBUS vs ZYXI Comparison
Compare CBUS & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBUS
- ZYXI
- Stock Information
- Founded
- CBUS 2010
- ZYXI 1996
- Country
- CBUS United States
- ZYXI United States
- Employees
- CBUS N/A
- ZYXI N/A
- Industry
- CBUS Agricultural Chemicals
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CBUS Industrials
- ZYXI Health Care
- Exchange
- CBUS Nasdaq
- ZYXI Nasdaq
- Market Cap
- CBUS 65.3M
- ZYXI 72.3M
- IPO Year
- CBUS 2017
- ZYXI N/A
- Fundamental
- Price
- CBUS $1.55
- ZYXI $2.40
- Analyst Decision
- CBUS Strong Buy
- ZYXI Buy
- Analyst Count
- CBUS 3
- ZYXI 3
- Target Price
- CBUS $22.00
- ZYXI $6.00
- AVG Volume (30 Days)
- CBUS 927.1K
- ZYXI 252.9K
- Earning Date
- CBUS 08-07-2025
- ZYXI 07-24-2025
- Dividend Yield
- CBUS N/A
- ZYXI N/A
- EPS Growth
- CBUS N/A
- ZYXI N/A
- EPS
- CBUS N/A
- ZYXI N/A
- Revenue
- CBUS $4,751,000.00
- ZYXI $172,401,000.00
- Revenue This Year
- CBUS $32.97
- ZYXI N/A
- Revenue Next Year
- CBUS $66.40
- ZYXI $19.55
- P/E Ratio
- CBUS N/A
- ZYXI N/A
- Revenue Growth
- CBUS 104.78
- ZYXI N/A
- 52 Week Low
- CBUS $1.38
- ZYXI $1.66
- 52 Week High
- CBUS $10.77
- ZYXI $10.62
- Technical
- Relative Strength Index (RSI)
- CBUS 42.57
- ZYXI 56.38
- Support Level
- CBUS $1.40
- ZYXI $2.51
- Resistance Level
- CBUS $1.67
- ZYXI $2.72
- Average True Range (ATR)
- CBUS 0.14
- ZYXI 0.18
- MACD
- CBUS 0.02
- ZYXI 0.03
- Stochastic Oscillator
- CBUS 62.07
- ZYXI 69.51
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.